Addendum to: The association between adverse pregnancy outcomes and maternal factor V Leiden genotype. A meta-analysis

• References

• 1 Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. ThrombHaemost 2004; 91: 700-711.
• 2 Kupfeminc MJ, Eldor A, Steinman N. et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
• 3 Martinelli I, Legnani C, Bucciarelli P. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 428-431.
• 4 Verspycka E, Le Cam-Duchezb V, Goffinetc F. et al. Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants. BJOG 2002; 109: 28-33.
• 5 Kupferminc MJ, Many A, Bar-Am A. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. BJOG 2002; 109: 1373-1376.
• 6 Agorastos T, Karavida A, Lambropoulos A. et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med 2002; 12: 267-273.
• 7 Infante-Rivard C, Rivard GE, Yotov W V. et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347: 19-25.
• 8 Grandone E, Margaglione M, Colaizzo D. et al. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210)mutations. Haematologica 2002; 87: 177-181.
• 9 Alfirevic Z, Mousa HA, Martlew V. et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obs Gyn 2001; 97: 753-759.